Evidence map›Paper›PMID 41939647›Full record

ArticleCureus2026

Nitrous Oxide-Induced Myelopathy: A Case From French-Speaking Switzerland.

Alain Witzig, Jérôme de Massias de Bonne, Camille Galletti, Nicolas Garin

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alain WitzigInternal Medicine, Hôpital Riviera-Chablais, Rennaz, CHE.
Jérôme de Massias de BonneNeurology, Hôpital Riviera-Chablais, Rennaz, CHE.
Camille GallettiRadiology, Hôpital Riviera-Chablais, Rennaz, CHE.
Nicolas GarinInternal Medicine, Hôpital Riviera-Chablais, Rennaz, CHE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recreational nitrous oxide (N₂O) use has increased worldwide, driven by its accessibility, low cost, and perception as a harmless "party drug." Chronic or heavy use can cause neurological complications through functional vitamin B₁₂ deficiency. Despite its growing prevalence, such cases remain rarely documented in French-speaking Switzerland. Our patient is a 27-year-old man of Cape Verdean origin who presented with rapidly progressive paresthesia and gait ataxia following heavy N₂O inhalation. Neurological examination revealed profound sensory ataxia and loss of vibration sense in the lower limbs. Laboratory tests showed low serum vitamin B₁₂ with markedly elevated methylmalonic acid and homocysteine levels. Cervical MRI demonstrated a T2-weighted hyperintensity of the dorsal columns (C1-C5) with the characteristic "inverted V" sign, consistent with posterior column myelopathy. Nerve conduction studies were normal, excluding polyneuropathy. Treatment with hydroxocobalamin and methionine supplementation was initiated; folate was started concomitantly rather than after vitamin B₁₂ normalization. At the three-month follow-up, the patient had discontinued vitamin therapy and resumed N₂O use, with persistent sensory deficits and ataxic gait. This case illustrates a typical presentation of N₂O-induced dorsal myelopathy due to functional vitamin B₁₂ deficiency. It represents a rare and probably underreported occurrence in French-speaking Switzerland. Clinicians should maintain high suspicion for N₂O toxicity in young adults presenting with unexplained sensory ataxia. Early recognition, sustained abstinence, and appropriate vitamin B₁₂ replacement are crucial to prevent irreversible neurological damage.

Indexed as

cobalamin deficiencyneurotoxicitynitrous oxide myelopathyrecreational drug usesensory ataxiasubacute combined degeneration

Identifiers

PMID41939647
PMCPMC13049691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.